Drug Shortage Report for TRIFLUOPERAZINE
Report ID | 75655 |
Drug Identification Number | 00345539 |
Brand name | TRIFLUOPERAZINE |
Common or Proper name | Trifluoperazine |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | TRIFLUOPERAZINE |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BTL |
ATC code | N05AB |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-03-15 |
Estimated end date | 2022-10-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-01-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.